Coagulation and inflammatory markers in Alzheimer's and vascular dementia

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Atherosclerosis--an inflammatory disease

Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725 · see citing works

Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS‐AIREN International Workshop*

Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works

. Cerebral blood flow in dementia.

Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · see citing works

HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY

Meade, T. W., Brozović, M., Chakrabarti, R., Haines, A., Imeson, J., Mellows, S., Miller, G. J., North, W. R. S., Stirling, Y., & Thompson, S. G. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90111-x · Cited by 1,937 · see citing works

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

Kivipelto, M., Helkala, E.-L., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., & Nissinen, A. (2001) · BMJ · doi:10.1136/bmj.322.7300.1447 · Cited by 1,618 · see citing works

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

Albert Hofman, D., Ott, A., Breteler, M. M. B., Bots, M. L., Slooter, A. J. C., van Harskamp, F., van Duijn, C. M., Broeckhoven, C. V., & Grobbee, D. E. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09328-2 · Cited by 1,365 · see citing works

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · see citing works

Fibrinogen as a Cardiovascular Risk Factor

Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 998 · see citing works

Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.

YARNELL, J. W. G., Baker, I. A., Sweetnam, P. M., Bainton, D., O'Brien, J. R., WHITEHEAD, P. J., & Elwood, P. C. (1991) · Circulation · doi:10.1161/01.cir.83.3.836 · Cited by 915 · see citing works

Obituary. Rupert Samuel Bruce Pearson.

Dm, O. (1974) · PubMed · Cited by 759 · see citing works

Admission criteria for immunogerontological studies in man: The senieur protocol

Ligthart, G. J., Corberand, J. X., Fournier, C., Galanaud, P., Hijmans, W., Kennes, B., Müller-Hermelink, H. K., & Steinmann, G. G. (1984) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(84)90152-0 · Cited by 754 · see citing works

Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease

Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 730 · see citing works

Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s Disease

Notkola, I.-L., Sulkava, R. O., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., Tuomilehto, J., & Nissinen, A. (1998) · Neuroepidemiology · doi:10.1159/000026149 · Cited by 666 · see citing works

Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men

Heinrich, J., Balleisen, L., Schulte, H., Assmann, G., & van de Loo, J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.54 · Cited by 563 · see citing works

Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study

Lowe, G. D. O., Lee, A. J., Rumley, A., Price, J. F., & Fowkes, F. G. R. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.8532481.x · Cited by 550 · see citing works

Interleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease

Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546 · see citing works

von Willebrand factor: a marker of endothelial dysfunction in vascular disorders?

Lip, G. Y. H. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00039-4 · Cited by 457 · see citing works

Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study

Smith, F. B., Lee, A. J., Fowkes, F. G. R., Price, J. F., Rumley, A., & Lowe, G. D. O. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.3321 · Cited by 352 · see citing works

Lipoprotein(a) as a strong indicator for cerebrovascular disease.

Zenker, G., Költringer, P., Boné, G., et al. (1986) · Stroke · doi:10.1161/01.str.17.5.942 · Cited by 330 · see citing works

Prospective study of endogenous tissue plasminogen activator and risk of stroke

Ridker, P. M., Hennekens, C. H., Manson, J. E., Ridker, P. M., Vaughan, D. E., Stampfer, M. J., Vaughan, D. E., Hennekens, C. H., & Stampfer, M. J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90064-7 · Cited by 305 · see citing works

Association of Fibrinolytic Parameters With Early Atherosclerosis

Salomaa, V. V., Stinson, V., Kark, J. D., Folsom, A. R., DAVIS, C. E., & Wu, K. K. (1995) · Circulation · doi:10.1161/01.cir.91.2.284 · Cited by 286 · see citing works

Blood Viscosity and Elevated Carotid Intima-Media Thickness in Men and Women

Lee, A. J., Mowbray, P. I., Lowe, G. D. O., Rumley, A., Fowkes, F. G. R., & Allan, P. L. (1998) · Circulation · doi:10.1161/01.cir.97.15.1467 · Cited by 229 · see citing works

C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study

Folsom, A. R., Aleksic, N., Catellier, D., Juneja, H. S., & Wu, K. K. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124054 · Cited by 225 · see citing works

Blood Rheology, Cardiovascular Risk Factors, and Cardiovascular Disease: The West of Scotland Coronary Prevention Study

Rumley, A., Norrie, J. D., Ford, I., Shepherd, J., Cobbe, S. M., Macfarlane, P. W., Packard, C. J., Lowe, G. D. O., & The West of Scotland Coronary Prevention Study Group (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614066 · Cited by 208 · see citing works

Association of Variables of Coagulation, Fibrinolysis and Acute-phase with Atherosclerosis in Coronary and Peripheral Arteries and those Arteries Supplying the Brain

Heinrich, J., Schulte, H., Schönfeld, R., Köhler, E., & Assmann, G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653783 · Cited by 200 · see citing works

A Prospective Case-Control Study of Lipoprotein(a) Levels and Apo(a) Size and Risk of Coronary Heart Disease in Stanford Five-City Project Participants

Wild, S. H., Fortmann, S. P., & Marcovina, S. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.2.239 · Cited by 194 · see citing works

Platelet Activation in Alzheimer Disease

Sevush, S., Jy, W., Horstman, L. L., Mao, W., Kolodny, L., & Ahn, Y. S. (1998) · Archives of Neurology · doi:10.1001/archneur.55.4.530 · Cited by 184 · see citing works

Longitudinal Study of Inflammatory Factors in Serum, Cerebrospinal Fluid, and Brain Tissue in Alzheimer Disease

Lanzrein, A.-S., Johnston, C., Perry, V. H., Jobst, K. A., King, E. M., & Smith, A. D. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00016 · Cited by 178 · see citing works

Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections

Iwamoto, N., Nishiyama, E., Ohwada, J., & Arai, H. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90035-3 · Cited by 129 · see citing works

Assessment of hypercoagulable states by measurement of activation fragments and peptides

Boisclair, M. D. (1990) · Blood Reviews · doi:10.1016/0268-960x(90)90014-j · Cited by 123 · see citing works

‘Silent’ Cerebral Infarction Is Associated With Hypercoagulability, Endothelial Cell Damage, and High Lp(a) Levels in Elderly Japanese

Kario, K., Matsuo, T., Kobayashi, H., Asada, R., & Matsuo, M. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.6.734 · Cited by 111 · see citing works

Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants

Smith, Rumley, Lee, Leng, Fowkes, & Lowe (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00626.x · Cited by 100 · see citing works

Prediction of carotid stenosis progression by lipid and hematologic measurements

Grotta, J. C., Yatsu, P. M., Pettigrew, L. C., et al. (1989) · Neurology · doi:10.1212/wnl.39.10.1325 · Cited by 84 · see citing works

Risk Factors for Vascular Disease and Dementia

Breteler, M. M. B., Bots, M. L., Ott, A., & Albert Hofman, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022428 · Cited by 82 · see citing works

Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris

Vaziri, N. D., Kennedy, S. C., Kennedy, D. J., et al. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90198-k · Cited by 75 · see citing works

Hemostasis Abnormalities in Patients with Vascular Dementia and Alzheimer’s Disease

Mari, D., Parnetti, L., Coppola, R., Bottasso, B., Reboldi, G., Senin, U., & Mannucci, P. M. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650246 · Cited by 72 · see citing works

Nutritional Factors and Alzheimer's Disease

Reynish, W., Andrieu, S., Nourhashémi, F., & Vellas, B. J. (2001) · The Journals of Gerontology Series A · doi:10.1093/gerona/56.11.m675 · Cited by 70 · see citing works

Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues

Hino, H., Akiyama, H., Iseki, E., Kato, M., Kondo, H., Ikeda, K., & Kosaka, K. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01679-7 · Cited by 55 · see citing works

Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen.

Walzl, M., Lechner, H., Walzl, B., et al. (1993) · Stroke · doi:10.1161/01.str.24.10.1447 · Cited by 54 · see citing works

Cholesterol, endothelial function and cardiovascular disease

Wilkinson, I. B., & Cockcroft, J. R. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199806000-00009 · Cited by 53 · see citing works

Hemorheologic profiles of plasma fibrinogen and blood viscosity from silent to acute and chronic cerebral infarctions

Tsuda, Y., Satoh, K., Kitadai, M., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05309-9 · Cited by 51 · see citing works

Cognitive function and blood rheology: results from the Caerphilly cohort of older men

Elwood, P. C. (2001) · Age and Ageing · doi:10.1093/ageing/30.2.135 · Cited by 49 · see citing works

Coagulation and Fibrinolysis Markers and Risk of Dementia

Bots, M. L., Breteler, M. M. B., van Kooten, F., Haverkate, F., Meijer, P., Koudstaal, P. J., Grobbee, D. E., & Kluft, C. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022433 · Cited by 42 · see citing works

Haemostasis in ischaemic stroke and vascular dementia

Stott, D. J., Spilg, E. G., Campbell, A. M., et al. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200112000-00006 · Cited by 42 · see citing works

Lipoprotein(a) Phenotypes in Patients with Vascular Dementia

Urakami, K., Wada‐Isoe, K., Wakutani, Y., et al. (2000) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017226 · Cited by 39 · see citing works

Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels

Blake, G. J., Ridker, P. M., & Kuntz, K. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01914-9 · Cited by 39 · see citing works

VASCULAR DEMENTIA ITALIAN SULODEXIDE STUDY (VA.D.I.S.S.) CLINICAL AND BIOLOGICAL RESULTS

Parnetti, L., Mari, D., Abate, G., et al. (1997) · Thrombosis Research · doi:10.1016/s0049-3848(97)00122-9 · Cited by 33 · see citing works

INFLAMMATION AND ALZHEIMER'S DISEASE

Gupta, A., & Pansari, K. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11394.x · Cited by 31 · see citing works

Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay

Contois, J. H., Lammi‐Keefe, C. J., Vogel, S., McNamara, J. R., Wilson, P. W. F., Massov, T., & Schaefer, E. J. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06341-3 · Cited by 28 · see citing works

Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: the West Birmingham Stroke Project

Lip, G. Y. H., Blann, A. D., Farooqi, I. S., et al. (2001) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200106000-00012 · Cited by 27 · see citing works

Lipoprotein(a) and Cognitive Performances in an Elderly White Population

Sarti, C., Pantoni, L., Pracucci, G., et al. (2001) · Stroke · doi:10.1161/01.str.32.7.1678 · Cited by 25 · see citing works

C‐Reactive Protein, Statins, and the Primary Prevention of Atherosclerotic Cardiovascular Disease

Bermudez, E. A., & Ridker, P. M. (2002) · Preventive Cardiology · doi:10.1111/j.1520-037x.2002.1032.x · Cited by 22 · see citing works

Status of Treatment of Vascular Dementia

Lechner, H. (1998) · Neuroepidemiology · doi:10.1159/000026148 · Cited by 21 · see citing works

THE ASSOCIATION BETWEEN BLOOD COAGULATION MARKERS, ATHEROTHROMBOSIS AND DEMENTIA

Gupta, A., & Pansari, K. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb10437.x · Cited by 12 · see citing works

Plasma levels of thrombomodulin and lipoprotein (a) in patients with cerebral thrombosis

Seki, Y., Takahashi, H., Shibata, A., et al. (1997) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199710000-00003 · Cited by 7 · see citing works

High Factor-VII Activity in the Elderly is Related to Vascular Disease Through Activation of the Coagulation System

Kario, K., & Matsuo, T. (1994) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679400100211 · Cited by 6 · see citing works

Complex chromosomal mechanisms lead to APRT loss of heterozygosity in heteroploid cells

Shao, C., Gupta, P. K., Sun, Y., et al. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000134486 · Cited by 4 · see citing works

Lipoprotein(a), vascular dementia and Alzheimer's disease

Spada, R. S., Ferri, R., Roccasalva, G., Toscano, G., & Cosentino, F. (2001) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00163-7 · Cited by 4 · see citing works

[Significance of the coagulation and fibrinolytic parameters as predictors for carotid atherosclerosis].

Nomura, E., Kohriyama, T., Yamaguchi, S., et al. (1996) · PubMed · Cited by 4 · see citing works

[Lipoprotein (a) in Alzheimer's atherosclerosis].

Mooser, V. (2000) · PubMed · Cited by 3 · see citing works

Proinflammatory Cytokines, Aging, and Age-Related Diseases

Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094 · see citing works

Decreased C-Reactive Protein Levels in Alzheimer Disease

O'Bryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., Bottiglieri, T., Massman, P., & Diaz-Arrastia, R. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351832 · Cited by 103 · see citing works

Cognitive decline following acute viral infections: literature review and projections for post-COVID-19

Damiano, R. F., Guedes, B. F., de Rocca, C. C., de Pádua Serafim, A., Castro, L. H. M., Munhoz, C. D., Nitrini, R., Filho, G. B., Miguel, E. C., Lucchetti, G., et al. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01286-4 · Cited by 98 · see citing works

Amyloid Plaques Dissociate Pentameric to Monomeric C‐Reactive Protein: A Novel Pathomechanism Driving Cortical Inflammation in Alzheimer's Disease?

Strang, F., Scheichl, A., Chen, Y., Wang, X., Htun, N., Bassler, N., Eisenhardt, S. U., Habersberger, J., & Peter, K. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00539.x · Cited by 94 · see citing works

Neuroinflammation in Alzheimer’s disease: Pleiotropic roles for cytokines and neuronal pentraxins

Swanson, A., Wolf, T., Sitzmann, A., & Willette, A. A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.015 · Cited by 72 · see citing works

Deep phenotyping of Alzheimer’s disease leveraging electronic medical records identifies sex-specific clinical associations

Tang, A. S., Oskotsky, T., Havaldar, S., Mantyh, W. G., Bicak, M., Solsberg, C. W., Woldemariam, S., Zeng, B., Hu, Z., Oskotsky, B., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28273-0 · Cited by 45 · see citing works

Impaired Cardiac Function and Cognitive Brain Aging

van der Velpen, I. F., Yancy, C. W., Sorond, F. A., & Sabayan, B. (2017) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.07.008 · Cited by 41 · see citing works

Vascular Factors and Alzheimer Disease

Skoog, I. G., Kalaria, R. N., & Breteler, M. M. B. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199912003-00016 · Cited by 183 · see citing works

α1‐Antichymotrypsin as a possible biochemical marker for Alzheimer‐type dementia

Matsubara, E., Hirai, S., Amari, M., Shoji, M., Yamaguchi, H., Okamoto, K., Ishiguro, K., Harigaya, Y., & Wakabayashi, K. (1990) · Annals of Neurology · doi:10.1002/ana.410280414 · Cited by 146 · see citing works

Risk Factor and Behavioral Differences Between Vascular and Alzheimer's Dementias: The Pathway to End-Stage Disease

Cooper, J. K., & Mungas, D. (1993) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099300600105 · Cited by 57 · see citing works

Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease

Han, Y., Jia, J., Jia, X., Qin, W., & Wang, S. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.094 · Cited by 19 · see citing works

Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging

MacKnight, C., Rockwood, K., Awalt, E., & McDowell, I. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000064928 · Cited by 313 · see citing works